BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 18852354)

  • 1. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
    Schaffer BA; Bertram L; Miller BL; Mullin K; Weintraub S; Johnson N; Bigio EH; Mesulam M; Wiedau-Pazos M; Jackson GR; Cummings JL; Cantor RM; Levey AI; Tanzi RE; Geschwind DH
    Arch Neurol; 2008 Oct; 65(10):1368-74. PubMed ID: 18852354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
    Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A
    J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
    Kwok JB; Hallupp M; Loy CT; Chan DK; Woo J; Mellick GD; Buchanan DD; Silburn PA; Halliday GM; Schofield PR
    Ann Neurol; 2005 Dec; 58(6):829-39. PubMed ID: 16315267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.
    Zhang N; Yu JT; Yang Y; Yang J; Zhang W; Tan L
    Brain Res; 2011 May; 1391():147-53. PubMed ID: 21443865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
    Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
    Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.
    Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D
    Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.
    Sobrido MJ; Miller BL; Havlioglu N; Zhukareva V; Jiang Z; Nasreddine ZS; Lee VM; Chow TW; Wilhelmsen KC; Cummings JL; Wu JY; Geschwind DH
    Arch Neurol; 2003 May; 60(5):698-702. PubMed ID: 12756133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
    Rosso SM; van Herpen E; Pijnenburg YA; Schoonenboom NS; Scheltens P; Heutink P; van Swieten JC
    Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
    Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the tau gene in patients with early-onset Alzheimer's disease.
    Roks G; Dermaut B; Heutink P; Julliams A; Backhovens H; Van de Broeck M; Serneels S; Hofman A; Van Broeckhoven C; van Duijn CM; Cruts M
    Neurosci Lett; 1999 Dec; 277(2):137-9. PubMed ID: 10624829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.
    Chen JA; Wang Q; Davis-Turak J; Li Y; Karydas AM; Hsu SC; Sears RL; Chatzopoulou D; Huang AY; Wojta KJ; Klein E; Lee J; Beekly DL; Boxer A; Faber KM; Haase CM; Miller J; Poon WW; Rosen A; Rosen H; Sapozhnikova A; Shapira J; Varpetian A; Foroud TM; Levenson RW; Levey AI; Kukull WA; Mendez MF; Ringman J; Chui H; Cotman C; DeCarli C; Miller BL; Geschwind DH; Coppola G
    JAMA Neurol; 2015 Apr; 72(4):414-22. PubMed ID: 25706306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygous TREM2 mutations in frontotemporal dementia.
    Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
    Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene.
    Pickering-Brown SM; Richardson AM; Snowden JS; McDonagh AM; Burns A; Braude W; Baker M; Liu WK; Yen SH; Hardy J; Hutton M; Davies Y; Allsop D; Craufurd D; Neary D; Mann DM
    Brain; 2002 Apr; 125(Pt 4):732-51. PubMed ID: 11912108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
    Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
    Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease.
    Russ C; Lovestone S; Powell JF
    Mol Psychiatry; 2002; 7(1):104-9. PubMed ID: 11803455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease.
    Russ C; Lovestone S; Powell JF
    Mol Psychiatry; 2001 May; 6(3):320-4. PubMed ID: 11326302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
    Coppedè F; Mancuso M; Lo Gerfo A; Manca ML; Petrozzi L; Migliore L; Siciliano G; Murri L
    Neurosci Lett; 2007 Mar; 414(3):282-5. PubMed ID: 17240059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.